EV/EBITDA
0.35
-0.05-12.50%
17 min ago
Summary
- As of March 12, 2025, KROS EV/EBITDA is 0.35, with a fall of -0.05 (-12.50%) during the most recent trading day.
- Over the past year, KROS EV/EBITDA has increased by +14.24 (+102.52%).
- KROS EV/EBITDA is now -55.13% below its all-time high of 0.78.
Performance
KROS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
KROS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -12.5% | +12.6% | +2.0% |
| 1 m1 month | -55.1% | +55.3% | +15.2% |
| 3 m3 months | +128.5% | -128.3% | -35.6% |
| 6 m6 months | +103.7% | -103.8% | -78.7% |
| ytdytd | +177.8% | -176.7% | -25.8% |
| 1 y1 year | +102.5% | -103.0% | -82.6% |
| 5 y5 years | - | - | - |
KROS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -55.1% | 0.31 | +12.9% | |
| 3 m | 3-month | 0.78 | -55.1% | -1.39 | +125.2% |
| 6 m | 6-month | 0.78 | -55.1% | -12.22 | +102.9% |
| 1 y | 1-year | 0.78 | -55.1% | -14.24 | +102.5% |
| 3 y | 3-year | 0.78 | -55.1% | -21.38 | +101.6% |
| 5 y | 5-year | 0.78 | -55.1% | -47.80 | +100.7% |
| alltime | all time | 0.78 | -55.1% | -47.80 | +100.7% |
Keros Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.35(-177.8%) |
| 2024 | -0.45(-92.8%) |
| 2023 | -6.23(-38.7%) |
| Date | Value |
|---|---|
| 2022 | -10.16(-51.2%) |
| 2021 | -20.83(-31.3%) |
| 2020 | -30.30 |
FAQ
- What is Keros Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Keros Therapeutics?
- What is KROS EV/EBITDA year-to-date change?
- What is Keros Therapeutics EV/EBITDA year-on-year change?
What is Keros Therapeutics EV/EBITDA?
The current EV/EBITDA of KROS is 0.35
What is the all time high EV/EBITDA for Keros Therapeutics?
Keros Therapeutics all-time high EV/EBITDA is 0.78
What is KROS EV/EBITDA year-to-date change?
Keros Therapeutics EV/EBITDA has changed by +0.80 (+177.78%) since the beginning of the year
What is Keros Therapeutics EV/EBITDA year-on-year change?
Over the past year, KROS EV/EBITDA has changed by +14.24 (+102.52%)